CEA19 Polyclonal Antibody

induction:Down-regulated by dexamethasone (in vitro).,Belongs to the immunoglobulin superfamily. CEA family.,tissue specificity:Ubiquitous with highest expression in prostate, uterus, fetal brain, mammary gland, adrenal gland, skeletal muscle, small intestine, and kidney, and lower expression in lung, cerebellum, testis, liver, pancreas, bone marrow and ovary.,

The CEA19 Polyclonal Antibody is a highly specific and sensitive immunological tool designed for the detection and quantification of carcinoembryonic antigen (CEA) in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the CEA protein.

With its exceptional affinity and selectivity, the CEA19 Polyclonal Antibody offers reliable and accurate results in a wide range of applications, including enzyme-linked immunosorbent assays (ELISA), immunohistochemistry (IHC), and Western blotting. It exhibits minimal cross-reactivity with other antigens, ensuring precise and specific detection of CEA.

The CEA19 Polyclonal Antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for multiple experiments without compromising its quality. This antibody is manufactured under strict quality control measures, ensuring consistent performance and reproducibility.

Furthermore, the CEA19 Polyclonal Antibody demonstrates excellent stability, maintaining its activity even after long-term storage. Its robustness and durability make it an ideal choice for research laboratories, diagnostic centers, and pharmaceutical companies.

In summary, the CEA19 Polyclonal Antibody is a superior immunological reagent that enables accurate and sensitive detection of CEA. Its exceptional specificity, reliability, and versatility make it an indispensable tool for various applications in cancer research, diagnostics, and therapeutic development.